These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19451583)

  • 21. Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions.
    Tylicki L; Lizakowski S; Rutkowski B
    J Nephrol; 2012; 25(6):900-10. PubMed ID: 22684647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations.
    Turgut F; Balogun RA; Abdel-Rahman EM
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1330-9. PubMed ID: 20498247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Weber MA
    Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Contribution of diuretics to the treatment of hypertension in patients with CKD].
    Ura N; Yamaji I
    Nihon Jinzo Gakkai Shi; 2009; 51(4):446-50. PubMed ID: 19601551
    [No Abstract]   [Full Text] [Related]  

  • 25. [Efficacy of calcium channel blocker in hypertensive patients with chronic kidney disease].
    Morihira M; Kikuchi K; Nakagawa N; Fujino T; Hasebe N
    Nihon Jinzo Gakkai Shi; 2009; 51(4):451-5. PubMed ID: 19601552
    [No Abstract]   [Full Text] [Related]  

  • 26. [RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function].
    Ritz E
    MMW Fortschr Med; 2004 Sep; 146(38):12. PubMed ID: 15532423
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical studies on the blockade of the renin-angiotensin-aldosterone-system.
    Hennig L
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S53-8. PubMed ID: 12940534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.
    Kanno Y; Takenaka T; Nakamura T; Suzuki H
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):730-7. PubMed ID: 17699280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New concept of chronic kidney disease and blockade of renin-angiotensin system].
    Takeda T; Gejyo F
    Nihon Rinsho; 2007 Sep; 65(9):1727-33. PubMed ID: 17877002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blocking the renin-angiotensin system in chronic kidney disease].
    Segura J
    Nefrologia; 2004; 24 Suppl(6):101-12, 187-235. PubMed ID: 15696901
    [No Abstract]   [Full Text] [Related]  

  • 33. FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy.
    Jimenez J; Safranek S; Viera AJ
    Am Fam Physician; 2007 Aug; 76(3):423-4. PubMed ID: 17708144
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?
    Hilgers KF; Dötsch J; Rascher W; Mann JF
    Pediatr Nephrol; 2004 Sep; 19(9):956-61. PubMed ID: 15278690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
    Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA;
    Trials; 2015 Dec; 16():581. PubMed ID: 26686682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fabry nephropathy and the case for adjunctive renal therapy.
    Wanner C; Breunig F
    J Am Soc Nephrol; 2007 Sep; 18(9):2426-8. PubMed ID: 17699807
    [No Abstract]   [Full Text] [Related]  

  • 37. Slowing chronic kidney disease progression: results of prospective clinical trials in adults.
    Nguyen T; Toto RD
    Pediatr Nephrol; 2008 Sep; 23(9):1409-22. PubMed ID: 18324425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is ACEI superior to ARB for CKD?
    Imai E
    Intern Med; 2006; 45(4):179-81. PubMed ID: 16543686
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantation.
    Morath C; Schmied B; Mehrabi A; Weitz J; Schmidt J; Werner J; Buchler MW; Morcos M; Nawroth PP; Schwenger V; Doehler B; Opelz G; Zeier M
    Clin Transplant; 2009 Dec; 23 Suppl 21():33-6. PubMed ID: 19930314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors.
    Litwin M; Grenda R; Sladowska J; Antoniewicz J
    Pediatr Nephrol; 2006 Nov; 21(11):1716-22. PubMed ID: 16909244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.